Press Releases

Press Releases

XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company developing its lead product for the treatment of lupus, today announced it has completed the clinical trial design for its upcoming Phase 2 study of hCDR1 in the treatment of systemic lupus erythematosus (SLE). The global study is planned to commence in 2016,…

Press Releases

Amgen and UCB today announced positive top-line results for romosozumab from the pivotal Phase 3 placeBo-contRolled study evaluatIng the efficacy anD safety of romosozumab in treatinG mEn with osteoporosis (BRIDGE). These data showed the BRIDGE study met the primary endpoint, demonstrating a statistically significant increase in bone mineral density (BMD)…

Press Releases

Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, and Eisai Inc., the U.S. pharmaceutical subsidiary of the research-based human healthcare company  Eisai Co., Ltd , announced today a revised agreement for their chemotherapy-induced nausea and vomiting (CINV) franchise. Under the new arrangement, Helsinn Therapeutics Inc., the U.S.…

Press Releases

Breckenridge Pharmaceutical, Inc. announces the final approval by the U.S. Food and Drug Administration of the Abbreviated New Drug Application for Gabapentin Oral Solution 250 mg per 5 mL, which is AA rated to Neurontin®, a drug marketed by Pfizer. The product developer, Tris Pharma, will manufacture and supply, and…

Press Releases

Allergan plc, a leading global pharmaceutical company, today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Paclitaxel Protein-Bound Particles for Injectable Suspension, 100 mg/vial. Allergan's ANDA product is a generic version of Celgene's Abraxane®, which…

Press Releases

BDI Pharma, Inc. announced today the launch of its Drug Supply Chain Security Act (DSCSA) compliant solution with partner TraceLink. This new service provides customers a one-stop solution for accessing all T3 compliance data from BDI Pharma (transaction information, transaction history and transaction statements) in one central repository that will…

Press Releases

Bringing in voices from some of the most senior industry thought leaders from Bristol Myers Squibb, Merck, Pfizer, Roche and Critical Path Institute, Oxford Global proudly presents the Biomarkers and Precision Medicine USA Congress where the latest areas in Biomarkers in Discovery and Validation, Precision Medicine, Diagnostics development and Clinical…

Press Releases

Amgen today announced that a Delaware jury delivered a verdict in Amgen's favor in a trial on the validity of two Amgen patents that describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9). Amgen brought the patent infringement action in Federal Court in Delaware against Sanofi and…

Press Releases

Syros Pharmaceuticals today announced that it will present new preclinical data on its lead program SY-1425 in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), as well as on its first-in-class selective cyclin-dependent kinase 7 (CDK7) inhibitor program in acute leukemias. These data will be presented at the American Association…

Press Releases

Sound Pharmaceuticals today announced the appointment of Paul Rickey as Chief Financial Officer (CFO).  Paul Rickey, an experienced life sciences and technology industry executive, joined the company effective March 1, 2016. Paul will lead the company's financial and administrative operations. "Paul brings to our management team proven financial leadership and…